期刊文献+

尼麦角林联合血栓通注射液治疗缺血性眩晕的效果与安全性观察 被引量:6

Observation on the effect and safety of nicergoline combined with Xueshuantong injection in the treatment of ischemic vertigo
下载PDF
导出
摘要 目的探讨尼麦角林联合血栓通注射液治疗缺血性眩晕的效果与安全性。方法选取我院2016年10月~2018年2月诊治的130例缺血性眩晕患者作为研究对象,将其随机分为对照组和研究组,各65例。对照组在常规治疗基础上给予血栓通注射液进行治疗,研究组在对照组基础上给予尼麦角林进行治疗。对比分析两组患者治疗效果、治疗前后眩晕评分和颅脑动脉血流速度以及不良反应发生情况。结果研究组患者临床疗效显著高于对照组(P<0.05);两组患者经过治疗后眩晕症状评分均低于治疗前,但研究组患者治疗后评分低于对照组(P<0.05);治疗后两组患者LVAVm、RVAVm、BAVm均有所提高,其中研究组血流速度快于对照组(P<0.05);研究组不良反应发生情况低于对照组(P<0.05)。结论尼麦角林联合血栓通注射液治疗缺血性眩晕疗效显著,安全性高,值得在临床上推广。 Objective To investigate the efficacy and safety of nicergoline combined with Xueshuantong injection in the treatment of ischemic vertigo.Methods A total of 130 patients with ischemic vertigo who were diagnosed and treated in our hospital from October 2016 to February 2018 were selected as study subjects.They were randomly divided into the control group and the study group,with 65 cases in each group.The control group was given Xueshuantong injection on the basis of conventional treatment.The study group was given nicergoline on the basis of the control group.The therapeutic effects,the vertigo scores before and after treatment,the blood flow velocity of the cranial artery and the occurrence of adverse reactions were compared and analyzed between the two groups.Results The clinical efficacy in the study group was significantly higher than that in the control group(P<0.05);the scores of vertigo symptoms after treatment in the two groups were lower than those before treatment,but the scores in the study group after treatment were lower than those in the control group(P<0.05);after treatment,LVAVm,RVAVm and BAVm were improved in both groups,and the blood flow velocity in the study group was faster than that in the control group(P<0.05);the incidence of adverse reactions in the study group was lower than that in the control group(P<0.05).Conclusion Nicergoline combined with Xueshuantong injection is significantly effective in the treatment of ischemic vertigo,and the safety is high,which is worthy of clinical promotion.
作者 房萍 FANG Ping(Department of Neurology,the Third Hospital of Xuzhou Coal Mining Group,Xuzhou 221011,China)
出处 《中国现代医生》 2019年第25期54-57,共4页 China Modern Doctor
关键词 尼麦角林 血栓通注射液 缺血性眩晕 安全性 Nicergoline Xueshuantong injection Ischemic vertigo Safety
  • 相关文献

参考文献17

二级参考文献158

共引文献234

同被引文献57

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部